000			02119 a2200541 4500
005			20250514192703.0
264		0	_c20040916
008			200409s 0 0 eng d
022			_a0012-1797
024	7		_a10.2337/diabetes.53.7.1706 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaedler, Kathrin
245	0	0	_aGlucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. _h[electronic resource]
260			_bDiabetes _cJul 2004
300			_a1706-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aATP-Binding Cassette Transporters
650	0	4	_aAged
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology
650	0	4	_aCalcium _xmetabolism
650	0	4	_aCalcium Channels, L-Type _xmetabolism
650	0	4	_aCells, Cultured
650	0	4	_aCyclic S-Oxides _xpharmacology
650	0	4	_aDiazoxide _xpharmacology
650	0	4	_aDrug Synergism
650	0	4	_aEnzyme Activation _xphysiology
650	0	4	_aGlucose _xpharmacology
650	0	4	_aHumans
650	0	4	_aInterleukin-1 _xpharmacology
650	0	4	_aIslets of Langerhans _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aPotassium Channels _xdrug effects
650	0	4	_aPotassium Channels, Inwardly Rectifying _xdrug effects
650	0	4	_aReceptors, Drug
650	0	4	_aSulfonylurea Receptors
650	0	4	_aTolbutamide _xpharmacology
700	1		_aStørling, Joachim
700	1		_aSturis, Jeppe
700	1		_aZuellig, Richard A
700	1		_aSpinas, Giatgen A
700	1		_aArkhammar, Per O G
700	1		_aMandrup-Poulsen, Thomas
700	1		_aDonath, Marc Y
773	0		_tDiabetes _gvol. 53 _gno. 7 _gp. 1706-13
856	4	0	_uhttps://doi.org/10.2337/diabetes.53.7.1706 _zAvailable from publisher's website
999			_c14925222 _d14925222